The DivGro Weekly—19.08.22

104 Consecutive dividend increases

This week we received further real-time, tangible evidence of outstanding business progress when we collected our quarterly dividends from Texas Instruments, MarketAxess and Abbott.

Having marked our calendars, we look forward to receiving our quarterly dividends from Microsoft and Cintas shortly. 

Since DivGro's inception we have predicted and benefited from 104 consecutive dividend increases across our portfolio companies. The average rate of these dividend increases is 15.6%.

Abbott, throughout its 134-year history, has always challenged itself to become even better, advancing its quest to improve human health, and by doing so to create ever increasing shareholder value. Abbott keeps itself nimble and focused on commercialising its pipeline of emerging healthcare solutions and to do so has repeatedly spun out hugely successful divisions to its shareholders. One such example is the 2013 spinoff of Abbvie, housing several drugs including Humira, one of the most profitable drugs of all time. Instead of resting on its laurels of past successes, the willingness and ability to break into and win significant new markets has underpinned one of the longest and most successful dividend growth records, with Abbott having raised its dividend for 50 consecutive years.